Real-World data on HydroPearl embolization through the wrist

NCT ID NCT04272216

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed registry study collected real-world data on 99 patients receiving HydroPearl microspheres to block blood flow to conditions like uterine fibroids, arteriovenous malformations, hypervascular tumors, and benign prostatic hyperplasia. The procedure was done through the radial artery in the wrist instead of the groin. The goal was to measure how often the procedure succeeded and how often complications occurred.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HydroPearl microspheres
What this could lead to
If successful, this registry could confirm that radial access embolization with HydroPearl is safe and effective in routine practice, supporting its wider use.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection or other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS MALFORMATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Mount Sinai

    New York, New York, 11766, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • SLU Department of Radiology

    St Louis, Missouri, 63110, United States

  • UNC

    Chapel Hill, North Carolina, 27599, United States

  • University of California - Los Angeles

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.